'''Pivagabine''' ([[International Nonproprietary Name|INN]]; brand name '''Tonerg'''), also known as '''''N''-pivaloyl-γ-aminobutyric acid''' or '''''N''-pivaloyl-GABA''', is an [[antidepressant]] and [[anxiolytic]] [[drug]] which was introduced in [[Italy]] in 1997 for the treatment of [[Depression (mood)|depressive]] and [[maladaptive]] [[syndrome]]s. But it was discontinued in Italy (according to [[Martindale: The Complete Drug Reference|Martindale]]). Originally believed to function as a [[prodrug]] to [[GABA]],<ref name="pmid6634934">{{cite journal |vauthors=Bianchi M, Quadro G, Mourier G, Galzigna L | title = Pharmacokinetics and in vitro effects of a 4-aminobutyric acid derivative with anticonvulsant action | journal = Pharmacology | volume = 27 | issue = 4 | pages = 237–40 | year = 1983 | pmid = 6634934 | doi = 10.1159/000137876| url = }}</ref> pivagabine is now believed to act somehow via modulation of [[corticotropin-releasing factor]] (CRF).<ref name="pmid9450154">{{cite journal |vauthors=Scapagnini U, Matera M | title = Effects of pivagabine on psychophysical performance and behavioural response in experimental models of stress | journal = Arzneimittel-Forschung | volume = 47 | issue = 11A | pages = 1310–4 | date = November 1997 | pmid = 9450154 | doi = | url = }}</ref><ref name="pmid9450153">{{cite journal |vauthors=Esposito G, Luparini MR | title = Pivagabine: a novel psychoactive drug | journal = Arzneimittelforschung| volume = 47 | issue = 11A | pages = 1306–9 | date = November 1997 | pmid = 9450153 | doi = | url = }}</ref><ref name="pmid11287080">{{cite journal  |vauthors=Gerra G, Zaimovic A, Giusti F, etal | title = Pivagabine effects on neuroendocrine responses to experimentally-induced psychological stress in humans | journal = Behavioural Brain Research | volume = 122 | issue = 1 | pages = 93–101 | date = July 2001 | pmid = 11287080 | doi = 10.1016/S0166-4328(01)00177-2| url = http://linkinghub.elsevier.com/retrieve/pii/S0166-4328(01)00177-2}}</ref><ref name="pmid10101733">{{cite journal  |vauthors=Serra M, Concas A, Mostallino MC, etal | title = Antagonism by pivagabine of stress-induced changes in GABAA receptor function and corticotropin-releasing factor concentrations in rat brain | journal = Psychoneuroendocrinology | volume = 24 | issue = 3 | pages = 269–84 | date = April 1999 | pmid = 10101733 | doi = 10.1016/S0306-4530(98)00049-3| url = http://linkinghub.elsevier.com/retrieve/pii/S0306-4530(98)00049-3}}</ref><ref name="PapakostasFava2010">{{cite book|author1=George I. Papakostas|author2=Maurizio Fava|title=Pharmacotherapy for Depression and Treatment-resistant Depression|url=https://books.google.com/books?id=zigp-66vq0MC&pg=PA370|year=2010|publisher=World Scientific|isbn=978-981-4287-59-3|pages=370–}}</ref>
